A rare urinary JC virus reactivation after long-term therapy with rituximab

Int J Infect Dis. 2021 Feb:103:447-449. doi: 10.1016/j.ijid.2020.11.194. Epub 2020 Dec 2.

Abstract

The possible role of JC virus in determining urinary tract involvement has only recently been recognized. The case of a man with laboratory-confirmed JC virus replication in the urine after a maintenance schedule of rituximab administered for a lymphoproliferative disorder is reported herein. The patient developed severe renal and urinary tract impairment, characterized by the onset of nephropathy, bilateral ureteral strictures, and a serious reduction in vesical compliance, ultimately requiring an ileal neobladder configuration. The renal and urinary tract involvement was finally attributed to JC virus reactivation. This observation suggests that renal and urinary tract diseases related to JC virus might be associated with long-term rituximab treatment.

Keywords: Infection; JC virus; Kidney; Polyomavirus; Reactivation; Rituximab; Urinary.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents, Immunological / adverse effects*
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Humans
  • JC Virus / isolation & purification*
  • JC Virus / physiology
  • Kidney Diseases / drug therapy
  • Kidney Diseases / virology*
  • Linezolid / administration & dosage
  • Linezolid / therapeutic use
  • Lymphoproliferative Disorders / drug therapy
  • Male
  • Meropenem / administration & dosage
  • Meropenem / therapeutic use
  • Middle Aged
  • Mirtazapine / administration & dosage
  • Mirtazapine / therapeutic use
  • Polyomavirus Infections / urine
  • Polyomavirus Infections / virology
  • Rituximab / adverse effects*
  • Rituximab / therapeutic use*
  • Tumor Virus Infections / urine
  • Tumor Virus Infections / virology
  • Virus Activation
  • Virus Latency

Substances

  • Antineoplastic Agents, Immunological
  • Rituximab
  • Mirtazapine
  • Meropenem
  • Linezolid